Regeneron Pharmaceuticals, Inc.

FIL Ltd REGN
Report date
6/30/2026
Quarter
2026 Q2
Filed
8/13/2026
Shares
265,490
Value ($000)
165,544
Weight
0.1%
2019 Q4 - 2026 Q2 (26 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).